Seco-DuocarmycinDMG is a potent ADC cytotoxin payload designed for antibody-drug conjugates, inducing DNA damage and cell death. It improves therapeutic efficacy and precision in cancer treatments.
Structure of 1613286-55-7
* For research and manufacturing use only. We do not sell to patients.
Size | Price | Stock | Quantity |
---|---|---|---|
-- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Catalog | Product Name | CAS | Inquiry |
---|---|---|---|
BADC-00811 | Duocarmycin DM free base | 1116745-06-2 | |
BADC-00337 | Seco-Duocarmycin TM | 1142188-60-0 | |
BADC-00223 | Duocarmycin A | 118292-34-5 | |
BADC-00362 | Duocarmycin B1 | 124325-93-5 | |
BADC-00341 | Seco-Duocarmycin SA | 152785-82-5 | |
BADC-00605 | Duocarmycin TM | 157922-77-5 | |
BADC-00332 | Seco-DuocarmycinCN | 1613286-54-6 | |
BADC-00342 | Seco-Duocarmycin MA | 1613286-57-9 | |
BADC-00609 | Duocarmycin MB | 1613286-58-0 | |
BADC-00336 | Seco-Duocamycin GA | 1613286-59-1 |
Contact our experts today for pricing and comprehensive details on our ADC offerings.
From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.
Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.
Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.